Vera Therapeutics Inc

VERANASDAQ · USD
26.74USD0.00 (-0.19%)
135

Vera Therapeutics Inc (VERA) Implied Volatility Current

VERA implied volatility is 108%. IV Rank is 82%, placing current premiums in the top of their 52-week range.

Read more

Tracking VERA implied volatility helps you identify when options premiums on Vera Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Vera Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when VERA IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Vera Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For VERA, tracking metrics like VERA IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on VERA signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections and is under Phase 2 clinical trial. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc.

in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where VERA implied volatility sits today versus where it has been. Our scanner ranks Vera Therapeutics Inc implied volatility against its historical range, surfaces extremes in VERA IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Vera Therapeutics Inc IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
81.75%IV Rank
High

IV is near its yearly peak - premiums are expensive, favoring sellers.

Implied Volatility (30d)108.28%

IV Rank81.75%

Historical Volatility (30d)57.37%

IV - HV+50.91%

As of October 14, 2026

Trade options with IV on your side

Track VERA IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial